135 related articles for article (PubMed ID: 18212756)
1. Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a biomarker candidate.
Mounier CM; Wendum D; Greenspan E; Fléjou JF; Rosenberg DW; Lambeau G
Br J Cancer; 2008 Feb; 98(3):587-95. PubMed ID: 18212756
[TBL] [Abstract][Full Text] [Related]
2. Molecular details of secretory phospholipase A
Gupta P; Dash PK
Sci Rep; 2017 Sep; 7(1):11080. PubMed ID: 28894144
[TBL] [Abstract][Full Text] [Related]
3. Secreted PLA
Tanaka K; Dozono N; Neyama H; Nagai J; Tsukahara R; Nagayasu K; Kaneko S; Ueda H
Biochem Biophys Res Commun; 2021 Sep; 568():167-173. PubMed ID: 34237486
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of pterin-4a-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 in human colon cancer.
Eskinazi R; Thöny B; Svoboda M; Robberecht P; Dassesse D; Heizmann CW; Van Laethem JL; Resibois A
Am J Pathol; 1999 Oct; 155(4):1105-13. PubMed ID: 10514393
[TBL] [Abstract][Full Text] [Related]
5. Necl 4 and RNase 5 Are Important Biomarkers for Gastric and Colon Adenocarcinomas.
Sayar İ; Gökçe A; Demirtas L; Eken H; Çimen FK; Çimen O
Med Sci Monit; 2017 May; 23():2654-2659. PubMed ID: 28561015
[TBL] [Abstract][Full Text] [Related]
6. Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis.
Sato H; Kato R; Isogai Y; Saka G; Ohtsuki M; Taketomi Y; Yamamoto K; Tsutsumi K; Yamada J; Masuda S; Ishikawa Y; Ishii T; Kobayashi T; Ikeda K; Taguchi R; Hatakeyama S; Hara S; Kudo I; Itabe H; Murakami M
J Biol Chem; 2008 Nov; 283(48):33483-97. PubMed ID: 18801741
[TBL] [Abstract][Full Text] [Related]
7. Detailed survey of an
Ran R; Muñoz Briones J; Jena S; Anderson NL; Olson MR; Green LN; Brubaker DK
iScience; 2024 Apr; 27(4):109383. PubMed ID: 38523788
[TBL] [Abstract][Full Text] [Related]
8. PLA2G4A and ACHE modulate lipid profiles via glycerophospholipid metabolism in platinum-resistant gastric cancer.
Chen M; Zhang C; Li H; Zheng S; Li Y; Yuan M; Chen Y; Wu J; Sun Q
J Transl Med; 2024 Mar; 22(1):249. PubMed ID: 38454407
[TBL] [Abstract][Full Text] [Related]
9. Identifying prognostic characteristics of m6A-related glycolysis gene and predicting the immune infiltration landscape in bladder cancer.
Zhou G; Li Y; Ren X; Qin G; Zhang Z; Zhao H; Gao L; Jiang X
Cancer Cell Int; 2023 Nov; 23(1):300. PubMed ID: 38017469
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of Group 1B Phospholipase A
Haller AM; Wolfkiel PR; Jaeschke A; Hui DY
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003345
[TBL] [Abstract][Full Text] [Related]
11. Interplay between C1-inhibitor and group IIA secreted phospholipase A
Ferrara AL; Bova M; Petraroli A; Marasco D; Payré C; Fortuna S; Palestra F; Ciardi R; Marone G; Spadaro G; Lambeau G; Loffredo S
Immunol Res; 2023 Feb; 71(1):70-82. PubMed ID: 36385678
[TBL] [Abstract][Full Text] [Related]
12. Functional Modulation of Human Macrophages by Secreted Phospholipases A
Galdiero MR; Mormile I; Granata F; Loffredo S; Detoraki A; Della Casa F; Trocchia ML; Ventrici A; de Paulis A; Rossi FW
Biomedicines; 2022 Oct; 10(11):. PubMed ID: 36359283
[TBL] [Abstract][Full Text] [Related]
13. Identification of AGR2 Gene-Specific Expression Patterns Associated with Epithelial-Mesenchymal Transition.
Martisova A; Sommerova L; Krejci A; Selingerova I; Kolarova T; Zavadil Kokas F; Holanek M; Podhorec J; Kazda T; Hrstka R
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142758
[TBL] [Abstract][Full Text] [Related]
14. Simulating the restoration of normal gene expression from different thyroid cancer stages using deep learning.
Nelligan NM; Bender MR; Feltus FA
BMC Cancer; 2022 Jun; 22(1):612. PubMed ID: 35659616
[TBL] [Abstract][Full Text] [Related]
15. Secretory Phospholipase A2 Digital Expression Analysis in Colon Adenocarcinoma.
Falidas E; Kitsiouli E; Spyropoulou D; Tsiambas E; Kalogirou A; Tsouvelas G; Papadopoulos S; Mitsis M; Lekka M; Mastronikoli S; Peschos D; Dimas O; Vlachos K
In Vivo; 2022; 36(2):738-742. PubMed ID: 35241529
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Molecule PLA2G2D Is a Potential Prognostic Biomarker Correlating With Immune Cell Infiltration and the Expression of Immune Checkpoint Genes in Cervical Squamous Cell Carcinoma.
Liu H; Xu R; Gao C; Zhu T; Liu L; Yang Y; Zeng H; Huang Y; Wang H
Front Oncol; 2021; 11():755668. PubMed ID: 34733790
[TBL] [Abstract][Full Text] [Related]
17. A Novel Risk Model Based on Lipid Metabolism-Associated Genes Predicts Prognosis and Indicates Immune Microenvironment in Breast Cancer.
Ye Z; Zou S; Niu Z; Xu Z; Hu Y
Front Cell Dev Biol; 2021; 9():691676. PubMed ID: 34195202
[TBL] [Abstract][Full Text] [Related]
18. What do secreted phospholipases A
Pungerčar J; Bihl F; Lambeau G; Križaj I
Biochimie; 2021 Oct; 189():40-50. PubMed ID: 34097986
[TBL] [Abstract][Full Text] [Related]
19. Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization.
Ray U; Roy D; Jin L; Thirusangu P; Staub J; Xiao Y; Kalogera E; Wahner Hendrickson AE; Cullen GD; Goergen K; Oberg AL; Shridhar V
J Exp Clin Cancer Res; 2021 Jun; 40(1):182. PubMed ID: 34082797
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
